Deputy general manager of Xinjiang Baihua village Co., Ltd., listed in Shanghai A-share listed company, is A member of the investment committee of Baihua village. More than two decades ago, focused on Sino-US business operations and equity investment experience in biomedical fields. In 2007, returned to join Chenxing venture capital company, which was responsible for the development of early-stage equity investment business. Former general manager of Kangtaide Bio-technology (Shanghai) Co., Ltd. In June 2009, entrusted by Chengxin biological technology Co., Ltd. be responsible for the daily operation of Kunming Keling biotechnology (Tianjin) analysis and test center general manager,including enterprise financial budget and planning of world capital markets. Successively serviced in the Dupont, Vince , Ziggy and genetic laboratory work, participate in and lead from drug R&D, compound optimization, preclinical animal pharmacology and toxicology experiments to clinical trials and declared the United States food and drug administration (FDA). 

Dr. Li has more than 30 papers published in magazines and journals at home and abroad, and has obtained several patents for inventions. More than 50 times have been invited to report at international and domestic academic and investment conferences. He graduated from Brigham young university and has a master's degree in ecology and environmental science research center of the Chinese academy of sciences, and bachelor degree from Hebei university of science and technology (formerly Hebei institute of chemical technology).